Inhibition of mTOR signaling reduces PELP1-mediated tumor growth and therapy resistance

Medicine and Dentistry

• Synapsin I 100%
• Glutamic Acid 100%
• Proline 100%
• Leucine 100%
• mTOR Signaling 29%
• Therapy Resistance 17%
• Cells 17%
• Xenograft 11%
• Estrogen Receptor 11%
• Breast Cancer 11%
• Cytoplasm 11%
• Hormone Therapy 11%
• Mammalian Target of Rapamycin Inhibitor 11%
• Cancer Therapy 11%
• Neoplasm 5%
• Protein 5%
• Cancer Cell 5%
• In Vitro 5%
• Combination Therapy 5%
• Cancer Growth 5%
• Breast Tumor 5%
• Tumor Progression 5%
• Tumor Xenograft 5%
• Tumor Model 5%
• Phosphoinositide 3-Kinase 5%
• Proto Oncogene 5%
• Protein Serine Threonine Kinase 5%
• Rapamycin 5%
• Marker 5%
• Assay 5%
• Survival 5%
• Drug Delivery System 5%

Biochemistry, Genetics and Molecular Biology

• Proline 100%
• Leucine 100%
• Glutamic Acid 100%
• Protein 100%
• Mammalian Target of Rapamycin 70%
• mTOR Signaling 29%
• Estrogen Receptor 11%
• Cancer Cell 5%
• Proto Oncogene 5%
• Protein Complexes 5%
• Immunoprecipitation 5%
• Phosphoinositide 3-Kinase 5%
• Growth 5%
• Survival 5%
• Drug Targeting 5%
• Protein Serine-Threonine Kinase 5%